The 460-G06 treatment inhibited viral replication in a dose-dependent manner at a concentration range of 12.5–100 nM without a severe decrease in cell viability, similar to their inhibitory effect on both viral infection and Tat activity. Here, TAT is linked to viral infectious disease.